ArticleDiabetology international2023

Anti-GAD antibody-positive fulminant type 1 diabetes developed following SARS-CoV-2 vaccination.

Tomohito Izumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.